Table 3

A comparison of results from two disability outcome measures applied to alemtuzumab-treated patients

 Area under the curve category
Net worse (AUC value >0.5)
n=35
Net improved (AUC value <−0.5)
n=43
Unchanged (AUC value ≥−0.5, ≤0.5)
n=9
SAD
n=28
2620
SRD
n=30
0282
Neither SAD nor SRD
n=29
9137
  • AUC, Area under the curve; SAD, sustained accumulation of disability; SRD, sustained reduction in disability.